Chimeric antigen receptor-T cell treatment (CAR-T cell therapy) holds immense potential to revolutionize organ transplantation, particularly for patients who struggle to find a suitable match and are at high risk of rejection. This breakthrough therapy offers a beacon of hope, promising to significantly improve the outcomes and quality of life for these patients. Current research prioritizes using CAR-T cells obtained …
